| Lastest Insider Transactions Of Amylyx Pharmaceuticals, Inc. ( AMLX ) |
| Symbol | Company Name | Insider Name | Title | Date | Transation | Share | Price | Amount | File Date |
| AMLX | Amylyx Pharmaceuticals, Inc. | Firestone Karen | Directior | 2026-08-31 | Option Exercise | 50,000 | 3.40 | 170,250 | 2026-09-02 16:00:27 |
| AMLX | Amylyx Pharmaceuticals, Inc. | Mazzariello Gina | Chief Legal Officer | 2026-07-09 | Sell | 30,000 | 17.96 | 538,868 | 2026-07-13 16:00:02 |
| AMLX | Amylyx Pharmaceuticals, Inc. | Firestone Karen | Directior | 2026-05-21 | Buy | 3,800 | 13.51 | 51,338 | 2026-05-26 16:00:07 |
| AMLX | Amylyx Pharmaceuticals, Inc. | Klee Justin B. | Co-Chief Executive Officer | 2026-03-02 | Sell | 29,282 | 14.47 | 423,760 | 2026-03-04 16:00:13 |
| AMLX | Amylyx Pharmaceuticals, Inc. | Cohen Joshua B | Co-Chief Executive Officer | 2026-03-02 | Sell | 29,282 | 14.48 | 424,121 | 2026-03-04 16:00:10 |
| AMLX | Amylyx Pharmaceuticals, Inc. | Bedrosian Camille L | Chief Medical Officer | 2026-03-02 | Sell | 6,461 | 14.58 | 94,205 | 2026-03-04 16:00:07 |
| AMLX | Amylyx Pharmaceuticals, Inc. | FRATES JAMES M | Chief Financial Officer | 2026-03-02 | Sell | 7,909 | 14.52 | 114,851 | 2026-03-04 16:00:04 |
| AMLX | Amylyx Pharmaceuticals, Inc. | Mazzariello Gina | Chief Legal Officer | 2026-03-02 | Sell | 6,844 | 14.52 | 99,378 | 2026-03-04 16:00:02 |
| AMLX | Amylyx Pharmaceuticals, Inc. | Mazzariello Gina | Chief Legal Officer | 2026-02-23 | Sell | 3,419 | 14.14 | 48,352 | 2026-02-25 16:00:03 |
| AMLX | Amylyx Pharmaceuticals, Inc. | FRATES JAMES M | Chief Financial Officer | 2026-02-02 | Sell | 3,557 | 14.65 | 52,097 | 2026-02-04 16:05:19 |
| AMLX | Amylyx Pharmaceuticals, Inc. | Cohen Joshua B | Co-Chief Executive Officer | 2026-02-02 | Sell | 15,500 | 14.68 | 227,593 | 2026-02-04 16:05:16 |
| AMLX | Amylyx Pharmaceuticals, Inc. | Mazzariello Gina | Chief Legal Officer | 2026-02-02 | Sell | 3,448 | 14.65 | 50,516 | 2026-02-04 16:05:11 |
| AMLX | Amylyx Pharmaceuticals, Inc. | Klee Justin B. | Co-Chief Executive Officer | 2026-02-02 | Sell | 15,500 | 14.69 | 227,618 | 2026-02-04 16:05:08 |
| AMLX | Amylyx Pharmaceuticals, Inc. | Cohen Joshua B | Co-Chief Executive Officer | 2026-01-15 | Sell | 138,167 | 13.59 | 1,878,094 | 2026-01-20 21:46:27 |
| AMLX | Amylyx Pharmaceuticals, Inc. | Cohen Joshua B | Co-Chief Executive Officer | 2026-01-15 | Option Exercise | 200,000 | 7.57 | 1,514,000 | 2026-01-20 21:46:27 |
| AMLX | Amylyx Pharmaceuticals, Inc. | Klee Justin B. | Co-Chief Executive Officer | 2026-01-15 | Sell | 138,188 | 13.59 | 1,877,570 | 2026-01-20 21:46:02 |
| AMLX | Amylyx Pharmaceuticals, Inc. | Klee Justin B. | Co-Chief Executive Officer | 2026-01-15 | Option Exercise | 200,000 | 7.57 | 1,514,000 | 2026-01-20 21:46:02 |
| AMLX | Amylyx Pharmaceuticals, Inc. | FRATES JAMES M | Chief Financial Officer | 2026-01-06 | Sell | 3,326 | 11.11 | 36,954 | 2026-01-08 16:05:17 |
| AMLX | Amylyx Pharmaceuticals, Inc. | Cohen Joshua B | Co-Chief Executive Officer | 2026-01-06 | Sell | 7,715 | 11.09 | 85,596 | 2026-01-08 16:05:12 |
| AMLX | Amylyx Pharmaceuticals, Inc. | Klee Justin B. | Co-Chief Executive Officer | 2026-01-06 | Sell | 7,715 | 11.09 | 85,589 | 2026-01-08 16:05:08 |
| AMLX | Amylyx Pharmaceuticals, Inc. | Firestone Karen | Directior | 2025-12-23 | Buy | 8,100 | 12.45 | 100,845 | 2025-12-23 20:48:33 |
| AMLX | Amylyx Pharmaceuticals, Inc. | Bedrosian Camille L | Chief Medical Officer | 2025-12-01 | Sell | 6,580 | 14.35 | 94,418 | 2025-12-03 16:39:50 |
| AMLX | Amylyx Pharmaceuticals, Inc. | Mazzariello Gina | Chief Legal Officer | 2025-08-12 | Sell | 30,000 | 8.20 | 246,149 | 2025-08-14 16:20:11 |
| AMLX | Amylyx Pharmaceuticals, Inc. | Mazzariello Gina | Chief Legal Officer | 2025-08-12 | Sell | 30,000 | 8.20 | 246,149 | 2025-08-14 16:20:11 |
| AMLX | Amylyx Pharmaceuticals, Inc. | FRATES JAMES M | Chief Financial Officer | 2025-03-31 | Sell | 10,896 | 3.47 | 37,806 | 2025-04-02 17:22:59 |
| AMLX | Amylyx Pharmaceuticals, Inc. | Bedrosian Camille L | Chief Medical Officer | 2025-03-31 | Sell | 12,425 | 3.47 | 43,082 | 2025-04-02 17:14:24 |
| AMLX | Amylyx Pharmaceuticals, Inc. | Mazzariello Gina | Chief Legal Officer | 2025-03-31 | Sell | 9,192 | 3.48 | 31,954 | 2025-04-02 17:12:23 |
| AMLX | Amylyx Pharmaceuticals, Inc. | Cohen Joshua B | Co-Chief Executive Officer | 2025-03-31 | Sell | 21,490 | 3.47 | 74,482 | 2025-04-02 16:57:43 |
| AMLX | Amylyx Pharmaceuticals, Inc. | Klee Justin B. | Co-Chief Executive Officer | 2025-03-31 | Sell | 21,490 | 3.46 | 74,454 | 2025-04-02 16:52:50 |
| AMLX | Amylyx Pharmaceuticals, Inc. | Zeiher Bernhardt G | Directior | 2025-03-20 | Buy | 10,000 | 3.70 | 37,005 | 2025-03-24 16:15:37 |
| AMLX | Amylyx Pharmaceuticals, Inc. | Klee Justin B. | Co-Chief Executive Officer | 2025-03-03 | Sell | 4,595 | 3.15 | 14,483 | 2025-03-05 16:35:19 |
| AMLX | Amylyx Pharmaceuticals, Inc. | Cohen Joshua B | Co-Chief Executive Officer | 2025-03-03 | Sell | 4,595 | 3.17 | 14,549 | 2025-03-05 16:32:37 |
| AMLX | Amylyx Pharmaceuticals, Inc. | Mazzariello Gina | Chief Legal Officer | 2025-03-03 | Sell | 1,611 | 3.12 | 5,022 | 2025-03-05 16:32:20 |
| AMLX | Amylyx Pharmaceuticals, Inc. | Mazzariello Gina | Chief Legal Officer | 2025-02-24 | Sell | 4,169 | 3.15 | 13,145 | 2025-02-26 16:35:10 |
| AMLX | Amylyx Pharmaceuticals, Inc. | Klee Justin B. | Co-Chief Executive Officer | 2025-02-05 | Option Exercise | 36,310 | 1.57 | 57,007 | 2025-02-06 20:17:12 |
| AMLX | Amylyx Pharmaceuticals, Inc. | Mazzariello Gina | Chief Legal Officer | 2025-02-03 | Sell | 3,678 | 3.49 | 12,839 | 2025-02-05 16:58:27 |
| AMLX | Amylyx Pharmaceuticals, Inc. | Cohen Joshua B | Co-Chief Executive Officer | 2025-02-03 | Sell | 11,851 | 3.47 | 41,108 | 2025-02-05 16:55:39 |
| AMLX | Amylyx Pharmaceuticals, Inc. | Klee Justin B. | Co-Chief Executive Officer | 2025-02-03 | Sell | 11,855 | 3.47 | 41,104 | 2025-02-05 16:54:04 |
| AMLX | Amylyx Pharmaceuticals, Inc. | Klee Justin B. | Co-Chief Executive Officer | 2025-01-06 | Sell | 7,471 | 4.04 | 30,202 | 2025-01-08 17:29:55 |
| AMLX | Amylyx Pharmaceuticals, Inc. | Cohen Joshua B | Co-Chief Executive Officer | 2025-01-06 | Sell | 7,471 | 4.05 | 30,232 | 2025-01-08 17:26:01 |
| AMLX | Amylyx Pharmaceuticals, Inc. | Bedrosian Camille L | Chief Medical Officer | 2024-12-02 | Sell | 5,421 | 5.54 | 30,007 | 2024-12-03 17:21:26 |
| AMLX | Amylyx Pharmaceuticals, Inc. | Klee Justin B. | Co-Chief Executive Officer | 2024-11-04 | Option Exercise | 63,690 | 1.57 | 99,993 | 2024-11-06 19:24:39 |
| AMLX | Amylyx Pharmaceuticals, Inc. | Klee Justin B. | Co-Chief Executive Officer | 2024-09-30 | Sell | 18,589 | 3.20 | 59,429 | 2024-10-02 18:53:53 |
| AMLX | Amylyx Pharmaceuticals, Inc. | Cohen Joshua B | Co-Chief Executive Officer | 2024-09-30 | Sell | 18,589 | 3.20 | 59,414 | 2024-10-02 18:53:51 |
| AMLX | Amylyx Pharmaceuticals, Inc. | Bedrosian Camille L | Chief Medical Officer | 2024-09-30 | Sell | 11,442 | 3.20 | 36,559 | 2024-10-02 18:50:13 |
| AMLX | Amylyx Pharmaceuticals, Inc. | Mazzariello Gina | Chief Legal Officer | 2024-09-30 | Sell | 8,709 | 3.20 | 27,840 | 2024-10-02 18:48:20 |
| AMLX | Amylyx Pharmaceuticals, Inc. | Cohen Joshua B | Co-Chief Executive Officer | 2024-09-23 | Option Exercise | 1,857 | 1.57 | 2,915 | 2024-09-25 17:56:10 |
| AMLX | Amylyx Pharmaceuticals, Inc. | Cohen Joshua B | Co-Chief Executive Officer | 2024-09-12 | Option Exercise | 34,449 | 1.57 | 54,085 | 2024-09-16 17:39:13 |
| AMLX | Amylyx Pharmaceuticals, Inc. | FRATES JAMES M | Chief Financial Officer | 2024-09-12 | Buy | 40,000 | 2.53 | 101,368 | 2024-09-16 17:30:37 |
| AMLX | Amylyx Pharmaceuticals, Inc. | Quimi Daphne | Directior | 2024-05-14 | Buy | 5,000 | 1.89 | 9,436 | 2024-05-16 19:37:39 |
| AMLX | Amylyx Pharmaceuticals, Inc. | Mazzariello Gina | Chief Legal Officer | 2024-05-15 | Sell | 10,455 | 1.88 | 19,654 | 2024-05-16 19:36:33 |
| AMLX | Amylyx Pharmaceuticals, Inc. | Cohen Joshua B | Co-Chief Executive Officer | 2024-03-05 | Sell | 4,135 | 18.73 | 77,440 | 2024-03-07 16:05:17 |
| AMLX | Amylyx Pharmaceuticals, Inc. | Klee Justin B. | Co-Chief Executive Officer | 2024-03-05 | Sell | 4,135 | 18.73 | 77,440 | 2024-03-07 16:05:13 |
| AMLX | Amylyx Pharmaceuticals, Inc. | FRATES JAMES M | Chief Financial Officer | 2024-03-05 | Sell | 1,792 | 18.73 | 33,560 | 2024-03-07 16:05:11 |
| AMLX | Amylyx Pharmaceuticals, Inc. | Mazzariello Gina | Chief Legal Officer | 2024-03-05 | Sell | 1,540 | 18.73 | 28,841 | 2024-03-07 16:05:10 |
| AMLX | Amylyx Pharmaceuticals, Inc. | Mazzariello Gina | Chief Legal Officer | 2024-02-23 | Sell | 2,838 | 18.76 | 53,231 | 2024-02-27 17:59:17 |
| AMLX | Amylyx Pharmaceuticals, Inc. | Klee Justin B. | Co-Chief Executive Officer | 2024-01-09 | Sell | 5,841 | 16.33 | 95,372 | 2024-01-11 17:11:55 |
| AMLX | Amylyx Pharmaceuticals, Inc. | FRATES JAMES M | Chief Financial Officer | 2024-01-09 | Sell | 2,716 | 16.33 | 44,347 | 2024-01-11 17:11:49 |
| AMLX | Amylyx Pharmaceuticals, Inc. | Cohen Joshua B | Co-Chief Executive Officer | 2024-01-09 | Sell | 5,841 | 16.33 | 95,372 | 2024-01-11 17:10:55 |
| AMLX | Amylyx Pharmaceuticals, Inc. | Yeramian Patrick D | Chief Medical Officer | 2024-01-09 | Sell | 2,812 | 16.33 | 45,915 | 2024-01-11 17:04:56 |
| AMLX | Amylyx Pharmaceuticals, Inc. | Olinger Margaret | Chief Commercial Officer | 2023-12-27 | Option Exercise | 25,000 | 0.37 | 9,250 | 2023-12-29 16:07:35 |
| AMLX | Amylyx Pharmaceuticals, Inc. | Firestone Karen | Directior | 2023-12-15 | Buy | 4,000 | 14.97 | 59,880 | 2023-12-19 16:37:26 |
| AMLX | Amylyx Pharmaceuticals, Inc. | Cohen Joshua B | Co-Chief Executive Officer | 2023-11-16 | Option Exercise | 63,694 | 1.57 | 100,000 | 2023-11-20 20:20:39 |
| AMLX | Amylyx Pharmaceuticals, Inc. | FRATES JAMES M | Chief Financial Officer | 2023-08-23 | Option Exercise | 18,165 | 6.88 | 124,975 | 2023-08-24 16:15:54 |
| AMLX | Amylyx Pharmaceuticals, Inc. | Mazzariello Gina | Chief Legal Officer | 2023-08-15 | Sell | 6,164 | 20.88 | 128,686 | 2023-08-17 16:35:44 |
| AMLX | Amylyx Pharmaceuticals, Inc. | Olinger Margaret | Chief Commercial Officer | 2023-07-12 | Option Exercise | 20,000 | 0.37 | 7,400 | 2023-07-14 16:20:33 |
| AMLX | Amylyx Pharmaceuticals, Inc. | FRATES JAMES M | Chief Financial Officer | 2023-05-16 | Sell | 32,500 | 26.94 | 875,451 | 2023-05-18 20:54:37 |
| AMLX | Amylyx Pharmaceuticals, Inc. | FRATES JAMES M | Chief Financial Officer | 2023-05-16 | Option Exercise | 32,500 | 6.88 | 223,600 | 2023-05-18 20:54:37 |
| AMLX | Amylyx Pharmaceuticals, Inc. | Yeramian Patrick D | Chief Medical Officer | 2023-05-15 | Sell | 11,965 | 29.03 | 347,358 | 2023-05-17 16:58:42 |
| AMLX | Amylyx Pharmaceuticals, Inc. | Yeramian Patrick D | Chief Medical Officer | 2023-05-15 | Option Exercise | 11,965 | 5.68 | 67,991 | 2023-05-17 16:58:42 |
| AMLX | Amylyx Pharmaceuticals, Inc. | Yeramian Patrick D | Chief Medical Officer | 2023-04-17 | Sell | 49,579 | 30.54 | 1,513,942 | 2023-04-19 19:45:13 |
| AMLX | Amylyx Pharmaceuticals, Inc. | Yeramian Patrick D | Chief Medical Officer | 2023-04-17 | Option Exercise | 49,579 | 0.99 | 49,058 | 2023-04-19 19:45:13 |
| AMLX | Amylyx Pharmaceuticals, Inc. | Morningside Venture Investments Ltd | 10% Owner | 2023-03-29 | Sell | 29,048 | 30.45 | 884,512 | 2023-03-31 16:05:11 |
| AMLX | Amylyx Pharmaceuticals, Inc. | Morningside Venture Investments Ltd | 10% Owner | 2023-03-27 | Sell | 160,964 | 30.42 | 4,896,561 | 2023-03-29 16:05:31 |
| AMLX | Amylyx Pharmaceuticals, Inc. | FRATES JAMES M | Chief Financial Officer | 2023-03-16 | Sell | 32,500 | 31.89 | 1,036,459 | 2023-03-24 18:48:19 |
| AMLX | Amylyx Pharmaceuticals, Inc. | FRATES JAMES M | Chief Financial Officer | 2023-03-16 | Option Exercise | 32,500 | 6.88 | 223,600 | 2023-03-24 18:48:19 |
| AMLX | Amylyx Pharmaceuticals, Inc. | Yeramian Patrick D | Chief Medical Officer | 2023-03-16 | Sell | 54,627 | 31.87 | 1,741,200 | 2023-03-24 18:45:03 |
| AMLX | Amylyx Pharmaceuticals, Inc. | Yeramian Patrick D | Chief Medical Officer | 2023-03-16 | Option Exercise | 49,578 | 2.57 | 127,262 | 2023-03-24 18:45:03 |
| AMLX | Amylyx Pharmaceuticals, Inc. | Morningside Venture Investments Ltd | 10% Owner | 2023-03-21 | Sell | 63,448 | 31.91 | 2,024,495 | 2023-03-23 16:05:14 |
| AMLX | Amylyx Pharmaceuticals, Inc. | Klee Justin B. | Co-Chief Executive Officer | 2023-03-16 | Sell | 100,000 | 31.86 | 3,186,236 | 2023-03-20 20:31:01 |
| AMLX | Amylyx Pharmaceuticals, Inc. | MILNE GEORGE M JR | Directior | 2023-03-16 | Sell | 35,000 | 31.89 | 1,116,073 | 2023-03-20 20:25:57 |
| AMLX | Amylyx Pharmaceuticals, Inc. | Yeramian Patrick D | Chief Medical Officer | 2023-03-16 | Sell | 54,627 | 31.87 | 1,741,200 | 2023-03-20 20:25:55 |
| AMLX | Amylyx Pharmaceuticals, Inc. | Firestone Karen | Directior | 2023-03-16 | Buy | 1,000 | 31.99 | 31,990 | 2023-03-20 20:22:25 |
| AMLX | Amylyx Pharmaceuticals, Inc. | Cohen Joshua B | Co-Chief Executive Officer | 2023-03-16 | Sell | 100,000 | 31.86 | 3,186,336 | 2023-03-20 20:21:04 |
| AMLX | Amylyx Pharmaceuticals, Inc. | FRATES JAMES M | Chief Financial Officer | 2023-03-16 | Sell | 32,500 | 31.89 | 1,036,459 | 2023-03-20 20:18:57 |
| AMLX | Amylyx Pharmaceuticals, Inc. | Morningside Venture Investments Ltd | 10% Owner | 2023-03-16 | Sell | 9,122 | 32.55 | 296,921 | 2023-03-17 16:05:09 |
| AMLX | Amylyx Pharmaceuticals, Inc. | Morningside Venture Investments Ltd | 10% Owner | 2023-03-14 | Sell | 220,714 | 33.68 | 7,433,459 | 2023-03-16 16:11:53 |
| AMLX | Amylyx Pharmaceuticals, Inc. | Morningside Venture Investments Ltd | 10% Owner | 2023-03-02 | Sell | 50,000 | 33.75 | 1,687,500 | 2023-03-06 09:10:38 |
| AMLX | Amylyx Pharmaceuticals, Inc. | Mazzariello Gina | Chief Legal Officer | 2023-02-24 | Sell | 3,586 | 34.49 | 123,672 | 2023-02-28 16:42:39 |
| AMLX | Amylyx Pharmaceuticals, Inc. | Morningside Venture Investments Ltd | 10% Owner | 2023-02-24 | Sell | 50,000 | 34.73 | 1,736,352 | 2023-02-28 16:06:25 |
| AMLX | Amylyx Pharmaceuticals, Inc. | Morningside Venture Investments Ltd | 10% Owner | 2023-02-22 | Sell | 100,000 | 35.78 | 3,578,103 | 2023-02-24 16:13:58 |
| AMLX | Amylyx Pharmaceuticals, Inc. | Yeramian Patrick D | Chief Medical Officer | 2023-01-06 | Sell | 2,034 | 36.30 | 73,831 | 2023-01-10 19:22:45 |
| AMLX | Amylyx Pharmaceuticals, Inc. | Cohen Joshua B | Co-Chief Executive Officer | 2023-01-06 | Sell | 5,968 | 36.30 | 216,629 | 2023-01-10 19:20:58 |
| AMLX | Amylyx Pharmaceuticals, Inc. | FRATES JAMES M | Chief Financial Officer | 2023-01-06 | Sell | 2,658 | 36.30 | 96,481 | 2023-01-10 19:20:38 |
| AMLX | Amylyx Pharmaceuticals, Inc. | Olinger Margaret | Chief Commercial Officer | 2023-01-06 | Sell | 2,403 | 36.30 | 87,225 | 2023-01-10 19:19:15 |
| AMLX | Amylyx Pharmaceuticals, Inc. | Klee Justin B. | Co-Chief Executive Officer | 2023-01-06 | Sell | 5,968 | 36.30 | 216,629 | 2023-01-10 19:12:48 |
| AMLX | Amylyx Pharmaceuticals, Inc. | FRATES JAMES M | Chief Financial Officer | 2022-12-30 | Option Exercise | 5,000 | 6.88 | 34,400 | 2023-01-04 21:33:55 |
